Podcast
PwC's Next in Health
Hosted by PwC's Health Industries · EN
Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.
26episodes
Episodes
Newest firstAll episodes
Next in medtech: Unlocking future growth in 3 strategic steps
Dec 10, 202400:13:14Tap to summarizeHow can medtech companies drive growth in today's market? Tune in as PwC specialists return to share key insights and strategies to help medtech companies invest in the capabilities required to compete in the future while aiming to exceed near-term expectations for growth and margin improvement.Key topics include:Challenges currently faced by medtech companiesReevaluating business models and new ways to playDriving returns on historical investments in technology by leveraging data and transforming legacy processesEmbracing a “high-tech” mindset to enable change and creating a culture of empowered decision makersUnlocking value through strategic M&ASpeakers:James Woods, Principal, PwCKevin McLellan, Principal, Strategy&, PwCLuna Corbetta, Principal, PwCJenny Colapietro, Consulting Commercial Leader, PwCMaterials:https://www.pwc.com/us/en/industries/health-industries/medical-technology/medtech-industry-insights.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →Election Impact: What to expect for the Health Industry
Nov 20, 202400:17:04Tap to summarizeWhat can the health industry expect from a second Trump administration? Tune in to hear what executives should watch over the next few months and years to come. Key topics include:President-elect Trump's healthcare agenda and his focus on deregulation, flexibility and choice, and accessibilityPotential implications for medicare, the ACA and IRA drug negotiationsWhat to watch in the first 100 daysSpeakers:Kelly Griffin, Director, Health Policy and Intelligence Institute Jenny Colapietro, Consulting Commercial Leader, PwCLinked materials:https://www.pwc.com/us/en/industries/health-industries/library/election-2024-trump-health-agenda.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →Boardroom essentials: Securing a seat on an emerging company board
Nov 15, 202400:16:11Tap to summarizeTune in as PwC specialists discuss best practices for securing a seat on an emerging company board. Key topics include:Types of emerging companiesResponsibilities of serving on emerging company boardsFive strategies for securing a board positionImportance of industry-specific expertise and continuous learningSpeakers:Holly Reeves, Partner, Emerging Company Solutions Market Leader, Health Industries, PwC USCarin Robinson, Director, Governance Insights Center, PwC US Jenny Colapietro, Consulting Commercial Leader, PwCFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →PwC's 2025 Medical cost trend report reveals rising healthcare costs
Sep 12, 202400:21:54Tap to summarizeTune in as authors of PwC's 2025 Medical Cost Trend Report: Behind the Numbers, discuss key findings and provide what employers should consider to manage rising healthcare costs. Key points include:Cost projections: The highest medical cost trend in 13 years, with an 8% increase for the group market and 7.5% for the individual marketKey drivers: Inflation, providers' cost-control efforts, increased use of prescription drugs, and new innovative therapiesStrategic adjustments: Employers should revise benefit plans and consider innovative solutions to manage rising costs while ensuring access to quality careSpeakers:Thom Bales, Health Services Advisory Leader, PwCPhil Sclafani, Principal, Pharmaceutical and Life Sciences, PwCJulian Levin, Principal, Actuarial Leader, PwCJenny Colapietro, Consulting Commercial Leader, PwCFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →The importance of physician enablement to our health ecosystem
Aug 29, 202400:18:03Tap to summarizeTune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Associate, Cailin Hong, on what physicians are seeking from payers, health systems and management services organizations (MSOs), to help improve the practice of medicine. This episode includes:Emerging business models and solutions that can enhance the physician experienceThe role of payers and providers in driving physician enablement within the health ecosystemActions health organizations should consider to help support and encourage their physicians For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →How emerging companies are navigating growth in the health industry
May 29, 202400:21:13Tap to summarizeTune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry. Key topics include:The journey and milestones of emerging companies in the life sciences, biotech and medical technology fields, including capital raising, product development and IPO preparationCommon pitfalls and best practices for managing diverse interests from investors and stakeholdersExamples of how emerging companies are leveraging AI and other technologies to prioritize programs, design clinical trials and communicate value propositionSpeakers:Holly Reeves, Health Industries - Emerging Company Solutions Market Leader, PwC USChristian Jester, Technology, Media & Telecommunications - Emerging Company Solutions Market Leader, PwC USJenny Colapietro, Health Industries Vice Chair, PwC, USFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Transcribe →